ArticleContemporary clinical trials communications2019
Pragmatic dose-escalation methods incorporating relative dose intensity assessment for molecularly targeted agents in phase I trials.
Akihiro Hirakawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.